Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Hemab Therapeutics Holdings, Inc. (COAG) had Tangible Shareholders Equity of -198.62M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-22.69M |
|
-- |
|
-- |
|
23.61M |
|
-23.61M |
|
0.94M |
|
-22.68M |
|
-22.68M |
|
-22.69M |
|
-22.69M |
|
-22.69M |
|
-22.69M |
|
-23.61M |
|
-23.54M |
|
0.95M |
|
0.95M |
|
-23.98 |
|
-23.98 |
|
| Balance Sheet Financials | |
169.43M |
|
0.65M |
|
5.83M |
|
175.26M |
|
13.19M |
|
-- |
|
360.69M |
|
373.88M |
|
-198.62M |
|
|
Tangible Shareholders Equity |
-198.62M |
-198.62M |
|
0.95M |
|
| Cash Flow Statement Financials | |
-21.58M |
|
-15.85M |
|
-0.46M |
|
87.97M |
|
49.86M |
|
-38.11M |
|
1.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
11.42% |
|
11.42% |
|
-12.94% |
|
11.42% |
|
-209.96 |
|
-22.93 |
|
-22.82 |
|